Li et al. [102] observed a strong correlation between AKR1B10 and HER2 positivity in ductal carcinoma in situ (DCIS), indicating the value of AKR1B10 as a potential diagnostic and prognostic marker for early breast cancers. The gene discussed is ERBB2; the disease is ductal breast carcinoma in situ.